# Qiaojing Capital

> Qiaojing Capital is a VC fund in Shanghai backing Health Care and Medical. See 14 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 14
- Last investment: Mar 2024
- Lead investor: 21%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/qiaojing-capital/
- Website: http://www.qjcap.com/

Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.

## Contacts

5 contacts available for Qiaojing Capital. Shizune tracks 3 team members at Qiaojing Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/qiaojing-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.4M–$35M |
| Series B | $9.9M–$14M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 50% |
| Medical | 6 | 43% |
| Medical Device | 4 | 29% |
| Manufacturing | 3 | 21% |
| Pharmaceutical | 2 | 14% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 50% |
| Series B | 4 | 29% |
| Angel | 1 | 7% |
| Series C | 1 | 7% |
| Funding Round | 1 | 7% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kim Min | Founding Partner | 0 | https://shizune.co/investors/profile/kim-min |
| Yu Zhe | Managing Director | 1 | https://shizune.co/investors/profile/yu-zhe |
| Zhu Haorong | Founding Partner | 0 | https://shizune.co/investors/profile/zhu-haorong |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Yisheng Microna | Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers. | $6.3M | Series A | Mar 13, 2024 |  |
| Elite Technology | Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production. | $14.1M | Angel | Jan 05, 2024 |  |
| Hicicare | Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices. | $14M | Series A | Dec 07, 2023 |  |
| Jianxin Biotech | Jianxin Bio focuses on new monoclonal antibody drugs, CAR-T (Chimeric Antigen Receptor T Cell) technology innovation. |  | Series B | Mar 20, 2023 |  |
| Jinfang Pharmaceutical | Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies. | $77.1M | Series C | Dec 31, 2021 |  |
| Leto Laboratories | Leto Laboratories is a manufacturer of protein products. | $14.2M | Series B | Oct 16, 2020 |  |
| Wanxu Software | Wanxu Software is a Healthcare company. | $2.9M | Series A | Aug 21, 2018 |  |
| Innostic | A Company Focused on Supply Chain Management of high value medical consumables. | $35.4M | Series A | Jan 30, 2018 |  |
| Oranger | Oranger is a developer of portable wearable medical devices, focused on the treatment of medical-grade chronic respiratory diseases such as sleep apnea. | $9.9M | Series B | Feb 24, 2017 |  |
| Wanshang Yizhan | Wanshang Yizhan is a B2B e-commerce transaction service platform. | $2.8M | Series A | Dec 31, 2016 |  |

10 of 14 investments shown.

## Co-investors
- [Chiron Ventures](https://shizune.co/investors/profile/chiron-ventures) — VC Fund, 3 deals together
- [Huagai Capital](https://shizune.co/investors/profile/huagai-capital) — VC Fund, 2 deals together
- [ABC International](https://shizune.co/investors/profile/abc-international) — VC Fund, 1 deal together
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 1 deal together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 1 deal together
- [Beijing Labtech Instruments](https://shizune.co/investors/profile/beijing-labtech-instruments) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)

## FAQ

### What does Qiaojing Capital invest in?

Qiaojing Capital invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Series B stage. Most of the 14 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Qiaojing Capital's check size?

Qiaojing Capital typically joins rounds of $1.4M–$35M at Series A and $9.9M–$14M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Qiaojing Capital participates in.

### How do I contact Qiaojing Capital?

Public channels for Qiaojing Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Qiaojing Capital?

The team at Qiaojing Capital includes Kim Min (Founding Partner), Yu Zhe (Managing Director) and Zhu Haorong (Founding Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co